Evidence map›Paper›PMID 28395733›Full record

ArticleeLife2017

Optical control of pain

Joan Font, Marc López-Cano, Serena Notartomaso, Pamela Scarselli, Paola Di Pietro, Roger Bresolí-Obach, Giuseppe Battaglia, Fanny Malhaire, Xavier Rovira, Juanlo Catena and 8 more

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in eLife, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 63 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Photoswitchable Serotonins for Optical Control of the 5-HTAngewandte Chemie (International ed. in English) · 2022
    Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

18 authors at 6 institutions in 3 countries.

Joan Font *MCS, Laboratory of Medicinal Chemistry, Institute for Advanced Chemistry of Catalonia (IQAC-CSIC), Barcelona, Spain.
Marc López-Cano *Departament de Patologia i Terapèutica Experimental, Facultat de Medicina i Ciències de la Salut, IDIBELL, Universitat de Barcelona, Barcelona, Spain.
Serena NotartomasoI.R.C.C.S. Neuromed, Pozzilli, Italy.ORCID http://orcid.org/0000-0003-4374-9233
Pamela ScarselliI.R.C.C.S. Neuromed, Pozzilli, Italy.ORCID http://orcid.org/0000-0002-4245-0849
Paola Di PietroI.R.C.C.S. Neuromed, Pozzilli, Italy.ORCID http://orcid.org/0000-0003-1327-1961
Roger Bresolí-ObachInstitut Químic de Sarrià, Universitat Ramon Llull, Barcelona, Spain.ORCID http://orcid.org/0000-0002-7819-7750
Giuseppe BattagliaI.R.C.C.S. Neuromed, Pozzilli, Italy.ORCID http://orcid.org/0000-0001-7571-3417
Fanny MalhaireIGF, CNRS, INSERM, Univ. Montpellier, Montpellier, France.
Xavier RoviraIGF, CNRS, INSERM, Univ. Montpellier, Montpellier, France.ORCID http://orcid.org/0000-0002-9764-9927
Juanlo CatenaMCS, Laboratory of Medicinal Chemistry, Institute for Advanced Chemistry of Catalonia (IQAC-CSIC), Barcelona, Spain.
Jesús GiraldoInstitut de Neurociències, Universitat Autònoma de Barcelona, Bellaterra, Spain.ORCID http://orcid.org/0000-0001-7082-4695
Jean-Philippe PinIGF, CNRS, INSERM, Univ. Montpellier, Montpellier, France.ORCID http://orcid.org/0000-0002-1423-345X
Víctor Fernández-DueñasDepartament de Patologia i Terapèutica Experimental, Facultat de Medicina i Ciències de la Salut, IDIBELL, Universitat de Barcelona, Barcelona, Spain.ORCID http://orcid.org/0000-0001-7834-2965
Cyril GoudetIGF, CNRS, INSERM, Univ. Montpellier, Montpellier, France.ORCID http://orcid.org/0000-0002-8255-3535
Santi NonellInstitut Químic de Sarrià, Universitat Ramon Llull, Barcelona, Spain.
Ferdinando NicolettiI.R.C.C.S. Neuromed, Pozzilli, Italy.ORCID http://orcid.org/0000-0003-0917-443X
Amadeu LlebariaMCS, Laboratory of Medicinal Chemistry, Institute for Advanced Chemistry of Catalonia (IQAC-CSIC), Barcelona, Spain.ORCID http://orcid.org/0000-0002-8200-4827
Francisco CiruelaDepartament de Patologia i Terapèutica Experimental, Facultat de Medicina i Ciències de la Salut, IDIBELL, Universitat de Barcelona, Barcelona, Spain.ORCID http://orcid.org/0000-0003-0832-3739
Istituto Neurologico Mediterraneo · ITCentre National de la Recherche Scientifique · FRInstitut d'Investigació Biomédica de Bellvitge · ESInstitute of Advanced Chemistry of Catalonia · ESInstitut Químic de Sarrià · ESUniversitat Autònoma de Barcelona · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Light-operated drugs constitute a major target in drug discovery, since they may provide spatiotemporal resolution for the treatment of complex diseases (i.e. chronic pain). JF-NP-26 is an inactive photocaged derivative of the metabotropic glutamate type 5 (mGlu

Indexed as

LightPainAllosteric RegulationAnalgesiaAnalgesicsAnimalsMiceNeuronsPhotosensitizing AgentsReceptor, Metabotropic Glutamate 5AnalgesicsPhotosensitizing AgentsReceptor, Metabotropic Glutamate 5allosteric modulationanalgesiamGlu5 receptormouseneuroscienceoptopharmacologypain neuraxis

Identifiers

PMID28395733
PMCPMC5388536
OpenAlexW2606995352

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.